New clinical trial results reveal gedatolisib significantly improves progression-free survival in advanced HR+/HER2– breast ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Learn how to build an infinite string and emerald farm in Minecraft 1.21+ using simple mob farming and villager trading ...

In a world of quick wins and impatient headlines, Martin Goebel is playing the long game. Now Director for Mexico at ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Celcuity recently released positive results from its phase 3 VIKTORIA-1 trial, and is raising both debt and shares. Read what ...

Jacob Sands, MD, discusses the data that support the FDA accelerated approval of Dato-DXd in EGFR-positive non–small cell ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...